Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -4.25%86.99K | -14.75%92.54K | 4.20%115.32K | -59.21%404.45K | 2.16%94.38K | -29.37%90.85K | -69.81%108.54K | -73.07%110.67K | -66.22%991.43K | -82.41%92.39K |
| Selling and administrative expenses | -28.00%38.73K | -23.41%44.66K | 4.28%113.09K | -43.31%379.47K | 410.70%222.52K | 224.67%53.79K | -49.99%58.31K | -60.83%108.44K | -67.98%669.33K | -80.58%43.57K |
| -General and administrative expense | -28.00%38.73K | -23.41%44.66K | 4.28%113.09K | -43.31%379.47K | 410.70%222.52K | 224.67%53.79K | -49.99%58.31K | -60.83%108.44K | -67.98%669.33K | -80.58%43.57K |
| Research and development costs | --0 | ---- | ---- | -94.77%16.06K | -41.90%28.36K | -133.04%-12.3K | --0 | --0 | -46.57%306.95K | -80.43%48.82K |
| Depreciation amortization depletion | --0 | --0 | 0.00%2.23K | -41.11%8.92K | 223,100.00%2.23K | 0.00%2.23K | 0.00%2.23K | -53.23%2.23K | -65.76%15.15K | -100.01%-1 |
| -Depreciation and amortization | --0 | --0 | 0.00%2.23K | -41.11%8.92K | 223,100.00%2.23K | 0.00%2.23K | 0.00%2.23K | -53.23%2.23K | -65.76%15.15K | -100.01%-1 |
| Other operating expenses | 2.40%48.26K | -0.26%47.88K | ---- | ---- | ---- | -35.09%47.13K | -41.48%48K | -5.13%63.61K | 15.78%261.53K | ---- |
| Operating profit | 4.25%-86.99K | 14.75%-92.54K | -4.20%-115.32K | 59.21%-404.45K | -2.16%-94.38K | 29.37%-90.85K | 69.81%-108.54K | 73.07%-110.67K | 66.22%-991.43K | 82.41%-92.39K |
| Net non-operating interest income (expenses) | 67.73%-19.24K | 78.97%-18.09K | 77.14%-17.6K | 79.77%-32.65K | 217.81%190.02K | -59.64K | -86.03K | -88,406.90%-77K | -11,757.97%-161.39K | -20,779.49%-161.3K |
| Non-operating interest expense | -67.73%19.24K | -78.97%18.09K | -77.14%17.6K | -79.77%32.65K | -217.81%-190.02K | --59.64K | --86.03K | 88,406.90%77K | 11,757.97%161.39K | 20,779.49%161.3K |
| Other net income (expenses) | -97.00%3.48K | 66.16%-5.92K | 4,252.01%66.02K | 545.57%176.62K | 517.14%76.63K | 3,738.46%115.96K | -964.98%-17.49K | 106.70%1.52K | 19.62%-39.64K | -116.21%-18.37K |
| Gain on sale of security | 114.80%3.48K | 66.16%-5.92K | -496.90%-6.02K | 182.33%32.63K | 492.50%72.1K | -877.79%-23.5K | -964.98%-17.49K | 106.70%1.52K | 19.62%-39.64K | -116.21%-18.37K |
| Special income (charges) | --0 | --0 | --72.04K | --4.53K | --4.53K | --0 | --0 | --0 | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---4.53K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | --0 | --72.04K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | --139.46K | --0 | --139.46K | ---- | ---- | ---- | ---- |
| Income before tax | -197.59%-102.76K | 45.04%-116.54K | 64.06%-66.9K | 78.16%-260.48K | 163.32%172.27K | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -197.59%-102.76K | 45.04%-116.54K | 64.06%-66.9K | 78.16%-260.48K | 163.32%172.27K | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K |
| Net income continuous operations | -197.59%-102.76K | 45.04%-116.54K | 64.06%-66.9K | 78.16%-260.48K | 163.32%172.27K | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -197.59%-102.76K | 45.04%-116.54K | 64.14%-66.77K | 78.16%-260.48K | 163.32%172.27K | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -197.59%-102.76K | 45.04%-116.54K | 64.14%-66.77K | 78.16%-260.48K | 163.32%172.27K | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K |
| Diluted earnings per share | -0.001 | 33.33%-0.002 | 66.67%-0.001 | 0 | 162.50%0.005 | 0 | 40.00%-0.003 | 50.00%-0.003 | 50.00%-0.02 | 60.00%-0.008 |
| Basic earnings per share | -0.001 | 33.33%-0.002 | 66.67%-0.001 | 0 | 162.50%0.005 | 0 | 40.00%-0.003 | 50.00%-0.003 | 50.00%-0.02 | 60.00%-0.008 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.